
### [NCIT:C80683](http://purl.obolibrary.org/obo/NCIT_C80683)
**Label:** Therapy-Related Leukemia

**Subclasses:** [NCIT:C80691](http://purl.obolibrary.org/obo/NCIT_C80691) (Chemotherapy-Related Leukemia), [NCIT:C27755](http://purl.obolibrary.org/obo/NCIT_C27755) (Topoisomerase II Inhibitor-Related Acute Myeloid Leukemia), [NCIT:C27754](http://purl.obolibrary.org/obo/NCIT_C27754) (Alkylating Agent-Related Acute Myeloid Leukemia), [NCIT:C8252](http://purl.obolibrary.org/obo/NCIT_C8252) (Therapy-Related Acute Myeloid Leukemia), 

**Class expressions from DL-Learner:**

- Thing 53.35%
- [NCIT:C42606](http://purl.obolibrary.org/obo/NCIT_C42606) (Chemotherapeutic Agent Toxicity) 52.94%
- [NCIT:C41362](http://purl.obolibrary.org/obo/NCIT_C41362) (Drug Exposure) 52.94%
- [NCIT:C37181](http://purl.obolibrary.org/obo/NCIT_C37181) (Neoplastic Monoblast) 52.94%
- [NCIT:C37076](http://purl.obolibrary.org/obo/NCIT_C37076) (Neoplastic Neutrophilic Precursor) 52.94%
- [NCIT:C37075](http://purl.obolibrary.org/obo/NCIT_C37075) (Neoplastic Promonocyte) 52.94%
- [NCIT:C37041](http://purl.obolibrary.org/obo/NCIT_C37041) (Neoplastic Monocyte) 52.94%
- [NCIT:C37040](http://purl.obolibrary.org/obo/NCIT_C37040) (Abnormal Monocyte) 52.94%
- [NCIT:C37040](http://purl.obolibrary.org/obo/NCIT_C37040) (Abnormal Monocyte) and [NCIT:C41063](http://purl.obolibrary.org/obo/NCIT_C41063) (Neoplastic Myeloid Cell) 52.94%
- [NCIT:C42607](http://purl.obolibrary.org/obo/NCIT_C42607) (Therapy-Related Toxicity) 46.71%
- [NCIT:C42607](http://purl.obolibrary.org/obo/NCIT_C42607) (Therapy-Related Toxicity) and (not ([NCIT:C35845](http://purl.obolibrary.org/obo/NCIT_C35845) (Basal Cell Hyperplasia))) 46.71%
- [NCIT:C42607](http://purl.obolibrary.org/obo/NCIT_C42607) (Therapy-Related Toxicity) and (not ([NCIT:C35837](http://purl.obolibrary.org/obo/NCIT_C35837) (Salivary Gland Sialoblastoma))) 46.71%
- [NCIT:C42607](http://purl.obolibrary.org/obo/NCIT_C42607) (Therapy-Related Toxicity) and (not ([NCIT:C35836](http://purl.obolibrary.org/obo/NCIT_C35836) (Salivary Gland Sialadenoma Papilliferum))) 46.71%
- [NCIT:C42607](http://purl.obolibrary.org/obo/NCIT_C42607) (Therapy-Related Toxicity) and (not ([NCIT:C35835](http://purl.obolibrary.org/obo/NCIT_C35835) (Salivary Gland Inverted Ductal Papilloma))) 46.71%
- [NCIT:C42607](http://purl.obolibrary.org/obo/NCIT_C42607) (Therapy-Related Toxicity) and (not ([NCIT:C35833](http://purl.obolibrary.org/obo/NCIT_C35833) (Salivary Gland Cystadenoma))) 46.71%


